Pay in 4 interest-free payments of $22.88 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
8(9):e73960
Smiles: CC1NC2=C(C(C=1C(=O)OC)C1=CC=C(O1)C1C=CC(=CC=1)C(O)=O)C(=O)C1=CC=CC=C12
2-difluoropropanamide
3 L/kg in rats
Sofosbuvir 13CD3 (PSI-7977 13CD3) is the deuterium labeled Sofosbuvir
Sitagliptin phosphate ine(Oxedrine) 8(9):e73960Sitagliptin (INN; previously identified as MK 0431 and sold under the trade name Januvia) is an oral antihyperglycemic (anti diabetic drug) of the dipeptidyl peptidase 4 (DPP 4) inhibitor class. It was developed and is marketed by Merck & Co. This enzyme inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of
US$ 108.00
US$ 85.00
US$ 38.00
US$ 38.00
US$ 45.00
US$ 38.00
US$ 30.00
US$ 28.00
US$ 38.00
US$ 85.00
US$ 176.00